Wambolt & Associates, LLC Amgen Inc Transaction History
Wambolt & Associates, LLC
- $293 Million
- Q2 2025
A detailed history of Wambolt & Associates, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wambolt & Associates, LLC holds 811 shares of AMGN stock, worth $244,224. This represents 0.08% of its overall portfolio holdings.
Number of Shares
811Holding current value
$244,224% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding AMGN
# of Institutions
3,276Shares Held
441MCall Options Held
6.15MPut Options Held
7.25M-
Vanguard Group Inc Valley Forge, PA53.7MShares$16.2 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.9 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.84 Billion0.32% of portfolio
-
Capital International Investors Los Angeles, CA18.9MShares$5.69 Billion0.95% of portfolio
-
Capital World Investors Los Angeles, CA16.9MShares$5.08 Billion0.71% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $161B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...